In this update of the Canadian Cardiovascular Society heart failure (HF) guidelines, we provide
comprehensive recommendations and practical tips for the pharmacologic management …

Reports from case series have estimated the incidence of peripartum cardiomyopathy (PC)
at 1 case/1,485 live births to 1 case/15,000 live births and probable mortality rates of 7% to 60…

Cardiac allograft vasculopathy (CAV) remains the Achilles’ heel of long-term survival after
heart transplantation. Almost one-third of patients develop CAV by 5 years post-transplant and …

STUDY OBJECTIVE: Acute cardiogenic pulmonary edema is a common cause of respiratory
distress in emergency department (ED) patients. Noninvasive ventilation by noninvasive …

In this update, we focus on selected topics of high clinical relevance for health care providers
who treat patients with heart failure (HF), on the basis of clinical trials published after 2017. …

Background: Sacubitril/Valsartan has been shown to improve mortality and reduce
hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF). The effect of …

Background— There remains limited insight into the pathophysiology and therapeutic
advances directed at improving prognosis for patients with heart failure with preserved ejection …

… Philip Joseph, MD, 1 Ambuj Roy, MD, 2 Eva Lonn, MD, 1 Stefan Störk, MD, 3 John Floras,
MD, 4 Lisa Mielniczuk, MD, 5 Jean-Lucien Rouleau, MD, 6 Jun Zhu, MD, 7 Anastase Dzudie …

Introduction Both types of sleep‐disordered breathing (SDB), obstructive and central sleep
apnoea (OSA and CSA, respectively), are common in patients with heart failure and reduced …

Background— Cardiac allograft vasculopathy is a key prognostic determinant after heart
transplant. Detection and risk stratification of patients with cardiac allograft vasculopathy are …